Back To Schedule
Sunday, June 14 • 1:30pm - 5:00pm
SC33: #33: R&D QA Comprehensive Quality Strategy: An Approach to Managing Quality Risks Throughout the Drug Development Lifecycle

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Tutorial
CE: ACPE 3.25 Knowledge UAN: 0286-0000-20-511-L04-P; CME 3.25; IACET 3.25; RN 3.25

Preregistration required. Already registered? Log in to DIA's My Account>My Events.

Quality oversight of drugs throughout the product development lifecycle is complex and crosses many functions, and at times it can be challenging to communicate and manage the quality risks identified along the way. This short course will begin with a brief review of ICH E6 (R2) and the impact to the clinical development enterprise. The group will then examine points to consider regarding the principles and benefits of a quality management framework as a foundation in setting tolerance limits, managing issues, identifying and mitigating risks, and applying analytics as part of quality risk management.
The instructors will take you through the development of a cross functional quality strategy frame work in an R&D QA organization which, when implemented, will proactively identify, manage, and communicate quality risks across the R&D GxP functions throughout drug development lifecycle. Examples will be workshopped to demonstrate how this methodology can help assure confidence in the quality oversight in preparation for submission to regulatory agencies and for inspections.
Back to DIA 2020 Short Courses

Who should attend?

This short course is designed for professionals within sponsor, CRO, and regulatory agency organizations interested in research and development, clinical research, and/or clinical quality assurance

Learning Objectives

Describe the risk process;Design a comprehensive quality strategy to manage risk throughout the drug lifecycle;Establish Quality Tolerance Limits and Issue Management;Discuss ways to implement a cross functional quality strategy frame work to identify, manage, and communicate quality risks across the R&D GxP functions.

avatar for Tim Grey

Tim Grey

Senior Director,R&D Quality Systems, AbbVie, Inc.
Tim Grey joined AbbVie in December 2013. He is currently Senior Director of Research and Development Quality Assurance leading the Quality Systems and Support Services team which includes Quality Systems, Documentation Management, training, QKM, QRM, CAPA, Qualification and Validation... Read More →
avatar for Victoria Burk

Victoria Burk

Senior Director R&D Quality Assurance, AbbVie, Inc.
Vicki Burk is the Sr. Director R&D Quality Assurance Clinical QA Program Management, Combination Products and Medical Devices and the Comprehensive Quality Strategy at AbbVie.  She leads teams responsible for Clinical QA across all stages of development and Combination Product/Medical... Read More →

Sunday June 14, 2020 1:30pm - 5:00pm EDT
TBD Virtual Event Horsham, PA 19044
  Short Courses, Tutorial |   08: R-D Quality-Compliance, Tutorial |   02: ClinTrials -ClinOps, Tutorial
  • Featured Topics ICH
  • Credit Type ACPE, CME, IACET, RN
  • Tags Tutorial